Nusivertib clinical trials

A Study of Oral Nuvisertib (TP-3654) in Patients With Myelofibrosis

This study is testing a new medicine, nuvisertib, for myelofibrosis. It aims to see if it's safe and how it works, either alone or with ruxolitinib. It's for people whose current treatments aren’t working well.